Dr. Gaston speaking to a group

2020 Scholar-Innovators

Rizwan Haq, MD, PhD

Rizwan Haq, MD, PhD

Dana-Farber Cancer Institute

A Small Molecule that Targets Cancers with Dysregulated KEAP-NRF2 Signaling

Michael Holtzman, MD

Michael Holtzman, MD

Washington University

A New Drug to Correct Epithelial Stem Cell Reprogramming in Airway Disease

Kyu Rhee, MD, PhD

Kyu Rhee, MD, PhD

Weill Cornell Medicine

New and Selective Inhibitors of Tuberculosis

Stephen Strittmatter, MD, PhD

Stephen Strittmatter, MD, PhD

Yale University

Prion Protein Antagonist for Alzheimer’s Disease and Creutzfeldt-Jakob Disease

Donald Weaver, MD, PhD, FRCP(C)

Donald Weaver, MD, PhD, FRCP(C)

University Health Network (Canada)

Targeting Immunopathy to Treat Alzheimer’s Disease

Timothy Yu, MD, PhD

Timothy Yu, MD, PhD

Boston Children’s Hospital

Personalized Splice-Modulating Oligonucleotide Therapy For Niemann-Pick Disease

The Harrington Project for Discovery & Development

Discover
Advance
Commercialize
Breakthrough Medicine